JIR
GSK icon

James Investment Research’s GSK GSK Stock Holding History

James Investment Research’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-39
Closed -$2K – 491
2020
Q2 		$2K Hold
39
– – ﹤0.01% 433
2020
Q1 		$2K Buy
+39
New +$2.08K ﹤0.01% 441
2019
Q3 		– Sell
-244
Closed -$12K – 597
2019
Q2 		$12K Hold
244
– – ﹤0.01% 576
2019
Q1 		$13K Buy
+244
New +$12.2K ﹤0.01% 716

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

James Investment Research's GSK Position: Q3 2020 in Review

James Investment Research sold out of GSK (GSK) in Q3 2020, closing a stake of 39 shares — an estimated $2K sold.

James Investment Research first reported a position in GSK in Q1 2019 and held it in 4 quarters. The position peaked at $13K in Q1 2019. 827 funds tracked by Wall St. Rank hold GSK as of Q3 2020.

  • James Investment Research reported no remaining GSK position as of Q3 2020 after selling out during the quarter.
  • James Investment Research sold 39 GSK shares in Q3 2020, an estimated $2K.
  • James Investment Research first reported a position in GSK in Q1 2019 and held it in 4 quarters.
  • James Investment Research's GSK position peaked at $13K in Q1 2019.
  • 827 funds tracked by Wall St. Rank held GSK as of Q3 2020.

Based on James Investment Research's 13F filing for Q3 2020, filed 23 Oct 2020.